Table 1.
Demographic and Clinical Characteristics of Patients Treated with Cognitive Enhancement Therapy or Enriched Supportive Therapy.
| Variable | CET (N = 31)
|
EST (N = 27)
|
pa |
|---|---|---|---|
| M (SD) | M (SD) | ||
| Demographics | |||
| Age | 25.88 (6.46) | 25.97 (6.26) | .955 |
| Male (N/%) | 20 (65%) | 20 (74%) | .617 |
| Caucasian (N/%) | 21 (68%) | 19 (70%) | .662 |
| Attended College (N/%) | 9 (29%) | 10 (37%) | .713 |
| Not Employed (N/%) | 8 (26%) | 7 (26%) | .772 |
| Schizophrenia (N/%) | 21 (68%) | 17 (63%) | .916 |
| Years Since First Psychotic Symptom | 3.07 (2.34) | 3.32 (2.16) | .675 |
| IQ | 97.74 (7.66) | 98.52 (9.74) | .736 |
| Symptoms | |||
| BPRS Total | 39.77 (9.21) | 40.70 (10.64) | .723 |
| Wing Negative Symptoms Scale | 18.35 (4.14) | 18.15 (3.63) | .842 |
| Raskin Depression Scale | 6.77 (2.77) | 6.33 (1.98) | .494 |
| Covi Anxiety Scale | 5.84 (2.08) | 6.11 (2.22) | .632 |
| Medications | |||
| Dose (baseline, cpz) | 405.38 (339.95) | 460.68 (335.05) | .536 |
| Dose (year 1, cpz) | 402.33 (332.93) | 529.38 (374.13) | .215 |
| Dose (year 2, cpz) | 473.58 (384.43) | 548.71 (402.05) | .520 |
Note. CET = Cognitive Enhancement Therapy, BPRS = Brief Psychiatric Rating Scale, EST = Enriched Supportive Therapy.
a
χ2 test or independent t-test, two-tailed, for significant differences between CET and EST participants.